Developer docs
API playgroundTry for free, no card

Search company profiles

JLL Partners

Full company profile

uuid0000b66

Namestring
JLL Partners
Legal namestring
JLL Partners, LLC and JLL Partners FCH, Inc.
Websiteurl
jllpartners.com
Company typeenum
Private
Founded yearint
1988
Descriptiontext

JLL Partners is a New York-based middle-market private equity firm founded in 1988 that invests across three sector verticals — Healthcare (pharmaceutical and life sciences services, devices and diagnostics, outsourced healthcare services), Industrials with a focus on Aerospace & Defense (aviation MRO, defense electronics enclosures, aerospace components, protective body armor, calibration and surface science), and Business Services (legal services and eDiscovery, information governance and specialty consulting, digital engineering). The firm raises successive private equity funds from institutional limited partners and has deployed approximately $8 billion of equity capital across nine funds and 61 platform investments with 183+ total acquisitions since inception; Fund IX closed at approximately $1.4 billion in February 2026, a meaningful step-up from the ~$866 million Fund VIII.

JLL's go-to-market is thesis-driven and proactive: the firm originates the majority of its deals through proprietary sourcing by an in-house business development team and a deep bench of ~15 strategic advisors with sector operating experience (former CEOs of Anthem/Wellpoint, Ambu, DaVita SVP-level, U.S. Navy Rear Admiral, frog design), supplemented by repeat co-investment with Water Street Healthcare Partners and selective use of sell-side advisors. Exits are executed via strategic acquirers (Thermo Fisher acquired Patheon in 2017 for ~$7B implied, Heartland Dental acquired American Dental Partners, Consilio acquired Xact Data Discovery in 2021, inVentiv Health acquired PharmaNet) and public markets (Patheon IPO on TSX in July 2016). Documented case-study outcomes include 6x EBITDA growth and 2x margin expansion at Patheon, 3x+ EBITDA growth and 10 accretive add-ons at Xact Data Discovery, and 8 accretive acquisitions and 11x EBITDA at Loar Group.

Short descriptiontext

JLL Partners is a New York-based middle-market private equity firm founded in 1988 that deploys ~$8B across nine funds into healthcare, industrials (A&D), and business services platforms via a thesis-driven, in-house value-creation model serving institutional LPs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
private equity investments, middle-market buyouts, healthcare investments, aerospace defense investing, business services acquisitions
Industry2 codes
PRIMARYFSANACAO
Multi-Sector / Generalist Growth Equity
SECONDARYFSAEALAI
Institutional Capital Introduction (LP/Family Office/Endowment Matching)
Financial & Insurance/Financial Advisory, Brokerage & Intermediation/Placement Agents & Capital Raising Intermediation
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Investment Banking and Securities Intermediation523150
SIC code1 code
  • Investment Advice6282
Product category
Middle-Market Private Equity
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Private equity fund management fees and carried interest
TypeManaged Services
Description

JLL Partners earns management fees and performance-based carried interest from the limited partners of its successive private equity funds. Fund IX closed at approximately $1.4 billion in equity commitments, exceeding its target and the ~$866 million predecessor fund. The firm has invested approximately $8 billion of equity capital across nine private equity funds with 61 platform investments since founding in 1988.

jllpartners.com
2Capital formation / fund investor relations services
TypeProfessional Services
Description

Capital is raised from institutional investors through a dedicated in-house Capital Formation team (led by Head of Capital Formation Cara Killackey), with routine ESG and performance updates provided to LPs.

jllpartners.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1Private equity fund commitments allocated via formal offering documents (not publicly priced)
ModelOtherBilling cadenceMulti-year contract
Notes

Fund IX closed at approximately $1.4 billion in equity commitments; predecessor fund approximately $866 million. Pricing terms (management fee, carried interest) are stated to be disclosed only in formal offering materials to qualified prospective investors.

jllpartners.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

JLL Partners is a middle-market private equity firm that raises capital from institutional limited partners through successive private equity funds (currently spanning Funds VI through IX) and deploys that capital into platform and add-on acquisitions across three sector-focused verticals: healthcare, industrials (including aerospace & defense), and business services. The firm combines in-house investment, operations, capital markets, and capital formation teams to source proprietary transactions, support portfolio company growth, and ultimately exit via strategic sale or public markets.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 6x EBITDA growth and 2x margin expansion at Patheon; capabilities across 75% of all dosage forms; ultimately sold to Thermo Fisher Scientific
+4 more records
Product overview1 text field

JLL Partners operates a private equity investment platform rather than a traditional software product suite, built around a series of middle-market funds (currently spanning Funds VI through IX, with Fund IX closed at approximately $1.4 billion in equity commitments). The platform is organized around three sector-specialized investment verticals—Healthcare, Industrials, and Business Services—each led by dedicated Managing Partners, which together form the core of how JLL deploys capital. Complementing these investment verticals are in-house Value Creation Services (including operational support led by Head of Value Creation Gerard van Spaendonck, technology implementation led by CTO Raj Bhavsar, and AI strategy led by Chief AI Officer Jeff Hunter) and an in-house Capital Markets platform led by Garrett Hall. The full ecosystem supports portfolio companies from acquisition through exit across healthcare, industrials, and business services sectors, with over $8 billion invested and committed capital across nine funds.

Product and service6 records
1JLL Partners Private Equity Funds
CategoryPrivate Equity Fund Platform
Description

A series of middle-market private equity funds (currently Funds VI through IX, with Fund IX closed at ~$1.4 billion in equity commitments), focused on transformative investments across the healthcare, industrials, and business services sectors. LPs commit capital via formal offering documents.

2JLL Partners Healthcare Investment Vertical
CategorySector Investment Vertical
Description

Sector specialization platform covering Pharmaceutical & Life Sciences, Devices & Diagnostics Technology, and Outsourced Healthcare Services; led by Managing Partner Dan Agroskin.

3JLL Partners Industrials Investment Vertical
CategorySector Investment Vertical
Description

Sector specialization platform covering Aerospace & Defense, Specialty Distribution, and Industrial Services; led by Managing Partner Kevin Hammond.

4JLL Partners Business Services Investment Vertical
CategorySector Investment Vertical
Description

Sector specialization platform covering Legal Services & Technology, Information Governance Consulting, and Financial; led by Managing Partner Frank Rodriguez.

5JLL Value Creation Services
CategoryOperational Service Platform
Description

In-house operations platform led by Head of Value Creation Gerard van Spaendonck, with Chief Technology Officer Raj Bhavsar and Chief AI Officer Jeff Hunter; supports portfolio companies with operational efficiencies, add-on acquisition integration, technology implementation, and growth strategies.

6JLL Partners Capital Markets Platform
CategoryCapital Markets Service
Description

In-house capital markets platform led by Managing Director Garrett Hall, providing financing coordination and oversight for new platform acquisitions and existing portfolio companies throughout the life of investments.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierMinorTypeOthersAnnounced on2026-02-23
Description

JLL Malaysia's capital markets data centres team lead Sum Chun Kit was interviewed for an educational article on data centres in The Edge Malaysia Weekly, covering hyperscale expansion in Johor and sustainability initiatives. This appears to reference Jones Lang LaSalle (JLL) Malaysia, a separate real estate services firm, not JLL Partners, the PE firm.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-26
Description

SDR Ventures served as sell-side advisor to Parks Medical Electronics on its acquisition by JLL Partners. Parks Medical is an Oregon-based medical device manufacturer of Doppler ultrasound systems and vascular testing equipment.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-11-05
Description

JLL Partners acquired and combined Parks Medical Electronics with Vascular Technology Incorporated to create a leading medical device company focused on vascular and robotics applications. The platform offers a comprehensive portfolio of Doppler ultrasound systems and vascular diagnostic systems serving healthcare professionals.

4JLL Partners (CDMO buy-and-build platforms)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-22
Description

Industry analysis identifies JLL Partners (alongside Vance Street Capital and Argosy Healthcare) as a private equity sponsor continuing to fuel CDMO consolidation through buy-and-build strategies, with specialization commanding significant valuation premiums.

medworldadvisors.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-05-01
Description

Heartland Dental announced a strategic transaction to acquire American Dental Partners Incorporated from JLL Partners. American Dental Partners operated hundreds of facilities in 20+ states.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-08-01
Description

JLL Partners and Water Street jointly acquired THREAD in August 2019. THREAD subsequently acquired Modus Outcomes (November 2021), CureClick (April 2022), and partnered with Amazon Web Services on a cloud-based AI-driven decentralized clinical trials technology platform (March 2022).

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

Consilio acquired Xact Data Discovery from JLL Partners in 2021. Xact Data Discovery was a successful JLL Fund VII investment in the eDiscovery / litigation support space, achieving 3x+ EBITDA growth under JLL ownership.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2017-05-01
Description

Thermo Fisher Scientific acquired Patheon, a leading contract development and manufacturing organization built by JLL Partners via a $2.6B deal with Royal DSM in 2013-2014. Patheon IPO'd in July 2016 and grew 6x EBITDA under JLL ownership prior to exit.

9Royal DSM
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2014-03-01
Description

JLL Partners formed a new pharma firm with Royal DSM in a $2.6 billion deal (November 2013) merging JLL's Patheon with DSM's pharmaceutical services division; merger closed March 2014. The transformational combination unlocked significant new business opportunities and enabled expansion across 75% of all dosage forms.

jllpartners.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Chicago-based middle-market private equity firm exclusively focused on healthcare. Most directly comparable to JLL: it is a repeat co-investment partner with JLL on healthcare platforms (EVERSANA, THREAD, BioClinica, Viant), shares the same healthcare-services and outsourced-services thesis, and competes for similar mid-market healthcare deals.

TypeDirect peer
Description

Long-tenured New York-based PE firm dedicated to healthcare and technology. Closely comparable to JLL's healthcare vertical in investment approach, fund size range, and focus on outsourced healthcare services and life sciences — a direct competitor for healthcare platforms and LPs.

TypeDirect peer
Description

Healthcare-focused middle-market PE firm. Comparable to JLL's healthcare vertical in target company size, healthcare services and pharma services orientation, and buy-and-build execution style; competes for similar outsourced-services platforms.

TypeDirect peer
Description

Chicago-based PE firm exclusively focused on healthcare (primarily healthcare services, pharma services, medical products). Closely comparable to JLL in healthcare-only thesis, middle-market check size, and concentration in regulated outsourced-services models.

TypeDirect peer
Description

Chicago-based middle-market PE firm with deep healthcare experience and a long history of sector-focused Leaders Strategy™ platforms. Highly comparable to JLL in fund size, healthcare emphasis, and repeatable build-and-buy execution model.

TypeDirect peer
Description

Middle-market PE firm focused on healthcare and industrial growth sectors. Comparable to JLL in two of its three verticals (healthcare services and industrials/specialty distribution) and in thesis-driven, sector-specialized deal-making.

TypeDirect peer
Description

Middle-market PE firm focused exclusively on industrials, including aerospace & defense, specialty industrial services, and distribution. Directly comparable to JLL's industrials vertical in focus areas (A&D, power generation components, calibration/industrial services) and in buy-and-build style.

TypeDirect peer
Description

Middle-market PE firm with deep healthcare services, life sciences, and business services focus. Comparable to JLL across two verticals (healthcare and business services) in target company size and thesis-driven, sector-specialized approach.

TypeBroad incumbent
Description

Global mega-fund with a dedicated U.S. healthcare and industrials platform. Overlaps with JLL in sector focus (JLL even bought Odyssey Behavioral Healthcare from Carlyle in 2024) but operates with significantly larger fund sizes and a more diversified sector footprint; competes for larger platforms and the same LP capital.

TypeBroad incumbent
Description

Global mega-fund with a dedicated Bain Capital Life Sciences and healthcare vertical. Comparable to JLL in healthcare thesis (outsourced services, life sciences) and in some business services exposure, but competes from a much larger fund base and broader geographic footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers29 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries28 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A13 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment9 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

JLL Partners

Middle-Market Private Equityjllpartners.com

JLL Partners is a New York-based middle-market private equity firm founded in 1988 that deploys ~$8B across nine funds into healthcare, industrials (A&D), and business services platforms via a thesis-driven, in-house value-creation model serving institutional LPs.

What JLL Partners does

JLL Partners is a New York-based middle-market private equity firm founded in 1988 that invests across three sector verticals — Healthcare (pharmaceutical and life sciences services, devices and diagnostics, outsourced healthcare services), Industrials with a focus on Aerospace & Defense (aviation MRO, defense electronics enclosures, aerospace components, protective body armor, calibration and surface science), and Business Services (legal services and eDiscovery, information governance and specialty consulting, digital engineering). The firm raises successive private equity funds from institutional limited partners and has deployed approximately $8 billion of equity capital across nine funds and 61 platform investments with 183+ total acquisitions since inception; Fund IX closed at approximately $1.4 billion in February 2026, a meaningful step-up from the ~$866 million Fund VIII.

JLL's go-to-market is thesis-driven and proactive: the firm originates the majority of its deals through proprietary sourcing by an in-house business development team and a deep bench of ~15 strategic advisors with sector operating experience (former CEOs of Anthem/Wellpoint, Ambu, DaVita SVP-level, U.S. Navy Rear Admiral, frog design), supplemented by repeat co-investment with Water Street Healthcare Partners and selective use of sell-side advisors. Exits are executed via strategic acquirers (Thermo Fisher acquired Patheon in 2017 for ~$7B implied, Heartland Dental acquired American Dental Partners, Consilio acquired Xact Data Discovery in 2021, inVentiv Health acquired PharmaNet) and public markets (Patheon IPO on TSX in July 2016). Documented case-study outcomes include 6x EBITDA growth and 2x margin expansion at Patheon, 3x+ EBITDA growth and 10 accretive add-ons at Xact Data Discovery, and 8 accretive acquisitions and 11x EBITDA at Loar Group.

JLL Partners firmographics

Firmographics
Name
JLL Partners
Legal name
JLL Partners, LLC and JLL Partners FCH, Inc.
Website
https://jllpartners.com
Company type
Private
Founded year
1988
Operating status
Operating
Headcount range
101–250 employees
Short description
JLL Partners is a New York-based middle-market private equity firm founded in 1988 that deploys ~$8B across nine funds into healthcare, industrials (A&D), and business services platforms via a thesis-driven, in-house value-creation model serving institutional LPs.
Ownership category
akta.pro rank

JLL Partners industry classification

Industry
Product category
Middle-Market Private Equity
NAICS
Portfolio Management and Investment Advice (523940), Investment Banking and Securities Intermediation (523150)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANACAO
Multi-Sector / Generalist Growth Equity
SECONDARYFSAEALAI
Institutional Capital Introduction (LP/Family Office/Endowment Matching)
Financial & Insurance/Financial Advisory, Brokerage & Intermediation/Placement Agents & Capital Raising Intermediation

Keywords

  • Private equity investments
  • Middle-market buyouts
  • Healthcare investments
  • Aerospace defense investing
  • Business services acquisitions

Where JLL Partners is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

JLL Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Private equity fund management fees and carried interest: JLL Partners earns management fees and performance-based carried interest from the limited partners of its successive private equity funds. Fund IX closed at approximately $1.4 billion in equity commitments, exceeding its target and the ~$866 million predecessor fund. The firm has invested approximately $8 billion of equity capital across nine private equity funds with 61 platform investments since founding in 1988.
  2. Capital formation / fund investor relations services: Capital is raised from institutional investors through a dedicated in-house Capital Formation team (led by Head of Capital Formation Cara Killackey), with routine ESG and performance updates provided to LPs.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractPrivate equity fund commitments allocated via formal offering documents (not publicly priced)

Go-to-market motion3 records

Distribution channels5 records

Marketing channels4 records

JLL Partners product offering

Product offering

Core offering

JLL Partners is a middle-market private equity firm that raises capital from institutional limited partners through successive private equity funds (currently spanning Funds VI through IX) and deploys that capital into platform and add-on acquisitions across three sector-focused verticals: healthcare, industrials (including aerospace & defense), and business services. The firm combines in-house investment, operations, capital markets, and capital formation teams to source proprietary transactions, support portfolio company growth, and ultimately exit via strategic sale or public markets.

Product overview

JLL Partners operates a private equity investment platform rather than a traditional software product suite, built around a series of middle-market funds (currently spanning Funds VI through IX, with Fund IX closed at approximately $1.4 billion in equity commitments). The platform is organized around three sector-specialized investment verticals—Healthcare, Industrials, and Business Services—each led by dedicated Managing Partners, which together form the core of how JLL deploys capital. Complementing these investment verticals are in-house Value Creation Services (including operational support led by Head of Value Creation Gerard van Spaendonck, technology implementation led by CTO Raj Bhavsar, and AI strategy led by Chief AI Officer Jeff Hunter) and an in-house Capital Markets platform led by Garrett Hall. The full ecosystem supports portfolio companies from acquisition through exit across healthcare, industrials, and business services sectors, with over $8 billion invested and committed capital across nine funds.

Differentiator

Problem solved

Functional benefit

Products and services

  • JLL Partners Private Equity Funds A series of middle-market private equity funds (currently Funds VI through IX, with Fund IX closed at ~$1.4 billion in equity commitments), focused on transformative investments across the healthcare, industrials, and business services sectors. LPs commit capital via formal offering documents.
  • JLL Partners Healthcare Investment Vertical Sector specialization platform covering Pharmaceutical & Life Sciences, Devices & Diagnostics Technology, and Outsourced Healthcare Services; led by Managing Partner Dan Agroskin.
  • JLL Partners Industrials Investment Vertical Sector specialization platform covering Aerospace & Defense, Specialty Distribution, and Industrial Services; led by Managing Partner Kevin Hammond.
  • JLL Partners Business Services Investment Vertical Sector specialization platform covering Legal Services & Technology, Information Governance Consulting, and Financial; led by Managing Partner Frank Rodriguez.
  • JLL Value Creation Services In-house operations platform led by Head of Value Creation Gerard van Spaendonck, with Chief Technology Officer Raj Bhavsar and Chief AI Officer Jeff Hunter; supports portfolio companies with operational efficiencies, add-on acquisition integration, technology implementation, and growth strategies.
  • JLL Partners Capital Markets Platform In-house capital markets platform led by Managing Director Garrett Hall, providing financing coordination and oversight for new platform acquisitions and existing portfolio companies throughout the life of investments.

Quantifiable outcome

  • 6x EBITDA growth and 2x margin expansion at Patheon; capabilities across 75% of all dosage forms; ultimately sold to Thermo Fisher Scientific
  • +4 more outcomes

Companies that use JLL Partners

Customer profile

Named customers29 records

Segments4 records

Ideal customer profiles4 records

JLL Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

JLL Partners partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered minor, flagship and core.

  • JLL Malaysia (Capital Markets Data Centres team)minorOthers · 23 February 2026JLL Malaysia's capital markets data centres team lead Sum Chun Kit was interviewed for an educational article on data centres in The Edge Malaysia Weekly, covering hyperscale expansion in Johor and sustainability initiatives. This appears to reference Jones Lang LaSalle (JLL) Malaysia, a separate real estate services firm, not JLL Partners, the PE firm.
  • SDR VenturesminorStrategic or Co-development Partner · 26 January 2026SDR Ventures served as sell-side advisor to Parks Medical Electronics on its acquisition by JLL Partners. Parks Medical is an Oregon-based medical device manufacturer of Doppler ultrasound systems and vascular testing equipment.
  • Parks Medical Electronics + Vascular Technology IncorporatedflagshipStrategic or Co-development Partner · 5 November 2025JLL Partners acquired and combined Parks Medical Electronics with Vascular Technology Incorporated to create a leading medical device company focused on vascular and robotics applications. The platform offers a comprehensive portfolio of Doppler ultrasound systems and vascular diagnostic systems serving healthcare professionals.
  • JLL Partners (CDMO buy-and-build platforms)coreStrategic or Co-development Partner · 22 October 2025Industry analysis identifies JLL Partners (alongside Vance Street Capital and Argosy Healthcare) as a private equity sponsor continuing to fuel CDMO consolidation through buy-and-build strategies, with specialization commanding significant valuation premiums.
  • Heartland DentalminorStrategic or Co-development Partner · 1 May 2021Heartland Dental announced a strategic transaction to acquire American Dental Partners Incorporated from JLL Partners. American Dental Partners operated hundreds of facilities in 20+ states.
  • THREADminorStrategic or Co-development Partner · 1 August 2019JLL Partners and Water Street jointly acquired THREAD in August 2019. THREAD subsequently acquired Modus Outcomes (November 2021), CureClick (April 2022), and partnered with Amazon Web Services on a cloud-based AI-driven decentralized clinical trials technology platform (March 2022).
  • ConsiliominorStrategic or Co-development Partner · 1 January 2018Consilio acquired Xact Data Discovery from JLL Partners in 2021. Xact Data Discovery was a successful JLL Fund VII investment in the eDiscovery / litigation support space, achieving 3x+ EBITDA growth under JLL ownership.
  • Thermo Fisher ScientificcoreStrategic or Co-development Partner · 1 May 2017Thermo Fisher Scientific acquired Patheon, a leading contract development and manufacturing organization built by JLL Partners via a $2.6B deal with Royal DSM in 2013-2014. Patheon IPO'd in July 2016 and grew 6x EBITDA under JLL ownership prior to exit.
  • Royal DSMflagshipStrategic or Co-development Partner · 1 March 2014JLL Partners formed a new pharma firm with Royal DSM in a $2.6 billion deal (November 2013) merging JLL's Patheon with DSM's pharmaceutical services division; merger closed March 2014. The transformational combination unlocked significant new business opportunities and enabled expansion across 75% of all dosage forms.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

JLL Partners competitors and assessment

Company assessment

Direct peers

  • Water Street Healthcare Partners: Chicago-based middle-market private equity firm exclusively focused on healthcare. Most directly comparable to JLL: it is a repeat co-investment partner with JLL on healthcare platforms (EVERSANA, THREAD, BioClinica, Viant), shares the same healthcare-services and outsourced-services thesis, and competes for similar mid-market healthcare deals.
  • Welsh, Carson, Anderson & Stowe: Long-tenured New York-based PE firm dedicated to healthcare and technology. Closely comparable to JLL's healthcare vertical in investment approach, fund size range, and focus on outsourced healthcare services and life sciences — a direct competitor for healthcare platforms and LPs.
  • Avista Capital Partners: Healthcare-focused middle-market PE firm. Comparable to JLL's healthcare vertical in target company size, healthcare services and pharma services orientation, and buy-and-build execution style; competes for similar outsourced-services platforms.
  • Linden Capital Partners: Chicago-based PE firm exclusively focused on healthcare (primarily healthcare services, pharma services, medical products). Closely comparable to JLL in healthcare-only thesis, middle-market check size, and concentration in regulated outsourced-services models.
  • GTCR LLC: Chicago-based middle-market PE firm with deep healthcare experience and a long history of sector-focused Leaders Strategy™ platforms. Highly comparable to JLL in fund size, healthcare emphasis, and repeatable build-and-buy execution model.
  • Arsenal Capital Partners: Middle-market PE firm focused on healthcare and industrial growth sectors. Comparable to JLL in two of its three verticals (healthcare services and industrials/specialty distribution) and in thesis-driven, sector-specialized deal-making.
  • American Industrial Partners: Middle-market PE firm focused exclusively on industrials, including aerospace & defense, specialty industrial services, and distribution. Directly comparable to JLL's industrials vertical in focus areas (A&D, power generation components, calibration/industrial services) and in buy-and-build style.
  • New Mountain Capital: Middle-market PE firm with deep healthcare services, life sciences, and business services focus. Comparable to JLL across two verticals (healthcare and business services) in target company size and thesis-driven, sector-specialized approach.

Broad incumbents

  • Carlyle Group: Global mega-fund with a dedicated U.S. healthcare and industrials platform. Overlaps with JLL in sector focus (JLL even bought Odyssey Behavioral Healthcare from Carlyle in 2024) but operates with significantly larger fund sizes and a more diversified sector footprint; competes for larger platforms and the same LP capital.
  • Bain Capital: Global mega-fund with a dedicated Bain Capital Life Sciences and healthcare vertical. Comparable to JLL in healthcare thesis (outsourced services, life sciences) and in some business services exposure, but competes from a much larger fund base and broader geographic footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

JLL Partners social profiles

Digital presence

JLL Partners compliance and trust

Trust signal

Compliance4 records

JLL Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

JLL Partners leadership team

Management profile

Number of profiles

Profiles17 records

JLL Partners subsidiaries and ownership

Company hierarchy

Subsidiaries28 records

JLL Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

JLL Partners M&A and investment

M&A and investment

M&A13 records

Investments9 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JLL Partners

What does JLL Partners do?

JLL Partners is a middle-market private equity firm that raises capital from institutional limited partners through successive private equity funds (currently spanning Funds VI through IX) and deploys that capital into platform and add-on acquisitions across three sector-focused verticals: healthcare, industrials (including aerospace & defense), and business services. The firm combines in-house investment, operations, capital markets, and capital formation teams to source proprietary transactions, support portfolio company growth, and ultimately exit via strategic sale or public markets.

Is JLL Partners a public or private company?

JLL Partners is a private company. It is classified as management employee owned and is currently operating.

When was JLL Partners founded?

JLL Partners was founded in 1988. It employs 101 to 250 people.

Where is JLL Partners based?

JLL Partners is headquartered in New York, United States, in the North America region.

How does JLL Partners make money?

Two revenue lines are on record. Private equity fund management fees and carried interest is the primary driver. The others are capital formation / fund investor relations services.

Who are JLL Partners's main competitors?

Direct peers on record are Water Street Healthcare Partners, Welsh, Carson, Anderson & Stowe, Avista Capital Partners, Linden Capital Partners, GTCR LLC, Arsenal Capital Partners, American Industrial Partners and New Mountain Capital. Broad incumbents are Carlyle Group and Bain Capital.

Does JLL Partners have an API?

No public API is recorded for JLL Partners.

What industry is JLL Partners in?

JLL Partners's product category is Middle-Market Private Equity. Its primary akta.pro industry code is FSANACAO, Multi-Sector / Generalist Growth Equity, with a secondary code of FSAEALAI, Institutional Capital Introduction (LP/Family Office/Endowment Matching). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0Signia Aerospace To Acquire Heads Up Technologies From JLL Partners To Expand Aircraft Cabin Systems BusinessSignia Aerospace agreed to acquire Heads Up Technologies from JLL Partners, expanding its aircraft cabin systems business. The deal adds cabin management, lighting, and electronics to Signia's portfolio, with financial advisers Harris Williams and Lincoln International. The acquisition aims to strengthen Signia's aftermarket and OEM presence.Pulse 2.0Bain Capital Provides €130 Million Credit Facility To Support JLL Partners’ Acquisition Of Life CouriersBain Capital provided a €130 million dual-currency senior credit facility to support JLL Partners' acquisition of Life Couriers, a global healthcare logistics provider. The facility, led by Bain Capital's Private Credit Group, builds on an existing relationship and aims to support Life Couriers' growth and expansion.citybizBain Capital Provides €130M Financing for JLL Partners’ Acquisition of Life CouriersBain Capital provided a €130 million dual-currency senior credit facility to support JLL Partners' acquisition of Life Couriers, a Munich-based healthcare logistics firm. The financing, led by Bain Capital's Private Credit Group, will support JLL Partners' investment in the company, which operates across six specialized segments. JLL Partners plans to support Life Couriers' continued growth and expansion.Business Wire BlogBain Capital Provides €130 Million Credit Facility to Support Acquisition of Life Couriers by JLL PartnersBain Capital's Private Credit Group led a €130 million dual-currency senior credit facility to support JLL Partners' acquisition of Life Couriers, a global healthcare logistics provider. The facility aims to support Life Couriers' growth and expansion plans under JLL's ownership.Business Wire BlogLife Couriers Announces Completion of Acquisition by JLL PartnersJLL Partners completed its acquisition of Life Couriers, appointing Edward DeMartini as CEO. The Munich-based healthcare logistics firm will benefit from JLL's healthcare expertise and new investment. Life Couriers plans to expand into additional geographic regions as demand for radiopharmaceutical and direct-to-patient delivery grows.Pulse 2.0JLL Partners Completes Life Couriers Acquisition And Names Edward DeMartini CEO To Drive Global ExpansionJLL Partners completed its acquisition of healthcare logistics firm Life Couriers and appointed Edward DeMartini as CEO. The Munich-based company operates six core businesses across the U.S., Europe, Central America, and Asia. JLL plans additional investment in people and operations as demand for radiopharmaceutical logistics grows.LifecouriersLife Couriers Announces Completion of Acquisition by JLL PartnersJLL Partners completed its acquisition of Life Couriers, a Munich-based healthcare logistics firm, and appointed Edward DeMartini as CEO. DeMartini succeeds Stefan Glebke, who will serve as strategic advisor. The company plans to expand into additional geographic regions.MorningstarLife Couriers Announces Completion of Acquisition by JLL PartnersJLL Partners completed its acquisition of Life Couriers, a global healthcare logistics provider, and appointed Edward DeMartini as CEO. DeMartini, previously CEO of The Quick Group, will succeed Stefan Glebke, who remains as strategic advisor. The company plans to expand into new geographic regions.Amazon Web ServicesDriving accelerated innovation & impact at the AWS Startups Investor SummitAWS Startups and Private Equity teams partnered with the National Association of Investment Companies (NAIC) to host an Investor Summit on September 19, 2024, inviting 64 underrepresented investor-led firms to discuss innovation and market dynamics. The event featured panels and sessions focused on leveraging AWS Cloud resources to reduce innovation costs and strategies for evaluating diverse-led funds. Key industry leaders from AWS, JLL Partners, Founder Collective, and Vista participated in discussions regarding digital transformation and investment trends.Third NewsCAI Completes Recapitalization with JLL Partners, Paving the Way for Future GrowthCAI, a professional services firm specializing in operational readiness for mission-critical industries, has completed a recapitalization deal with JLL Partners, a New York-based private equity firm, with NewVale Capital also joining as an investment partner. The transaction will enable CAI to pursue global expansion, particularly in Australia, and increase investments in human resources, advanced training, and next-generation technologies. CAI's CEO and CFO characterized the partnership as a pivotal moment that will enhance service offerings and position the company for future growth.